Sitaglu Met XR 50/1000mg Tablet 28s – Extended-Release Combination
Sitaglu Met XR 50/1000mg Tablet 28s – Extended-Release Combination
Description
Sitaglu Met XR 50/1000mg Tablet – Convenient Once-Daily Dual Therapy for Glycemic Stability
Sitaglu Met XR 50/1000mg Tab combines sitagliptin 50mg and extended-release metformin hydrochloride 1000mg to deliver effective, long-acting management for adults with type 2 diabetes. Sitagliptin enhances the body's incretin system to promote glucose-dependent insulin release and reduce glucagon secretion, while the extended-release metformin gradually improves insulin sensitivity and decreases hepatic glucose production over 24 hours. This dual mechanism provides robust HbA1c reduction and steady control of both fasting and post-meal blood sugar levels.
With its once-daily extended-release formulation, this tablet minimizes gastrointestinal side effects associated with immediate-release metformin, offering better tolerability and simpler adherence for patients needing combination therapy alongside diet and exercise under medical supervision.
